Beigene Drug Patent Portfolio

Beigene's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Beigene News

Market Unfazed by Drugmaker's Recovery Efforts - Benzinga

15 May, 2025

BeiGene marks a significant profit achievement driven by rising pharmaceutical sales - Insights for global investors in Chinese stocks.

15 May, 2025

Summit Therapeutics Reports Smaller-Than-Expected Loss in Q1, No Sales Recorded - TradingView

02 May, 2025

Reasons Behind Summit Therapeutics' Significant Surge Today - The Globe and Mail

23 Apr, 2025

See More